The Gulf Coast consortia CPRIT throughput screening program, a component of the John S. Dunn Gulf Coast Consortium for Chemical Genomics, is designed to provide researchers with access to resources only for scientists to work Texas in large pharmaceutical companies available. Robot and chemicals are among the available resources.
"We are thrilled that the work the Gulf Coast consortia is recognized in this way, and we love to see the results of this collaboration," said Kathleen Matthews, PhD., Chairman of the Committee of Gulf Coast consortia supervision and Stewart Memorial Professor of Biochemistry and cell biology at Rice University. "By access to these resources will help the program to translate the important discoveries researchers, that category be made in the research laboratory in new treatments for this disease."
Peter Davies, m.d., PhD., Provost and executive Vice President for research at the University of Texas Health Science Center in Houston (UTHealth), is the principal investigator and also serves as the program co-director with Michael Mancini, PhD., Associate Professor and Director of integrated microscopy of core at the Baylor College of medicine.
"The main objective of the programme is the movement of the fundamental discoveries in cancer research in clinical application through the provision of critical resources to explore research and Therapeutics development in Texas support to speed up", Davies said. "By combining State-of-the-art laboratory, cancer allows technologies with a demanding program of computer science for data mining and data sharing, the program to bring the most promising leads, new molecules or drugs that have the highest probability of success in the way for the development of novel cancer therapies researchers."
The Gulf Coast consortia combines the strengths of its six member institutions, to build interdisciplinary collaborative research teams and training programs in the Biological Sciences at its junction with the computational, chemical, mathematical and physical sciences. There is Rice University, University of Houston, from UTHealth, Baylor College of medicine, the University of Texas Medical Branch in Galveston and the University of Texas MD Anderson Cancer Center.
"This new award from CPRIT is strong to expand drug discovery functions for Cancer Therapeutics." Baylor College of medicine proud, a part of the Gulf Coast consortia programmes on cooperation among the scientists in the Gulf Coast region to promote ", said Timothy Palzkill, PhD., Professor and head of Department of Pharmacology at Baylor College of medicine."
Work on various elements of CPRIT throughput screening programme funded by the grant are UTHealth, the University of Texas MD Anderson Cancer Center, University of Texas at Austin, Rice University, Baylor College of medicine and the Methodist Hospital Research Institute.
"This is an exciting opportunity for the drug development efforts on the UT Austin Texas Institute for drugs and Diagnostics development." Through the partnership with the Gulf Coast consortia, we can efforts and functions in Austin that institutions use the Houston area. Such an unprecedented level of research coordination of the State of Texas an innovation in itself, one on a very fertile Foundation for many breakthroughs in our fight against cancer, will result ", said Brent Iverson, PhD., j. and viola Mae Raymer Professor and Chairman of the Department of chemistry and biochemistry at the UT Austin Warren.
Stephen WONG, PhD., the John S Dunn distinguished Chair endowed bio-medical engineering and Professor of Radiology, neuroscience, pathology and laboratory medicine at the Methodist Hospital Research Institute, added, "This will allow us, a hub and Texas on the map in the high-throughput drug discovery at the national level." We at Methodist are proud to be part of the team, that process, analyze, manage and disable mountains of drug screening information in credible hits for anti-cancer drugs. We are able, this high-throughput data with genomic combine and drugs based on databases, to identify the molecular pathway mechanism of different type of cancer. "
Building on the support of the John S. Dunn of health, is Foundation and UTHealth's clinical and translational Sciences Award from the national institutes it technology and administrative cores, as well as an information network of exchange for the promotion of cooperation and include data sharing between Texas cancer researchers.
"This is very exciting news for the institutions involved and research in Texas for the development of State-of-the-art high-throughput-technologies that can be applied to cancer." It helps investigators new targets, "Garth Powis, D. Phil, Chair of the Department who said Experimental Therapeutics and Director of the Center for targeted therapy for MD Anderson Cancer said new agents and approaches to the treatment of cancer, ultimately in Texas and nationwide, identifying the beneficiaries patients."
Members of the Gulf Coast consortia and its oversight committees said that the CPRIT prize of the consortia is spirit.
"Rice is eager, their role as partners in the training and information exchange aspect this vital programme to speed up the development of Cancer Therapeutics,", said Daniel Carson, PhD., Dean and Schlumberger Chair for advanced studies and research at the Wiess School of natural sciences at Rice University.
Texas leads the nation in its commitment to the cure of cancer. In 2007, voters Texas voted predominantly a constitutional amendment establishing the cancer prevention and research to Institute of Texas (CPRIT) and up to $3 billion investment in groundbreaking research and prevention programmes and services in Texas. CPRIT focuses on the innovation speed up and marketing of cancer research in turn increases the potential for a medical or scientific breakthrough and improving access to evidence-based prevention programmes and services.
"We are very excited that the high-throughput screening program tools is available to speed up the identification and development of new Therapeutics for cancer," said William new, Associate Dean for research administration at the University of Texas Medical Branch in Galveston.
Source: University of Texas Health Science Center in Houston
Posts
0 comments: on "Gulf Coast consortia awarded $ 12.6 million for cancer research"
Post a Comment